abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Total Non-Current Assets
$561.10M
Quarterly · Period ending: · USD
HQL Total Non-Current Assets
Latest reported$561.10Mperiod ending
Latest reported$561.10Mperiod ending
HQL Quarterly Non-Current Assets ($123.50M → $561.10M)
Quarterly total non-current assets
High-resolution chart · PNG
HQL total non-current assets history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Assets (USD) |
|---|---|
| 561,097,322 | |
| 514,129,502 | |
| 411,299,230 | |
| 474,202,603 | |
| 441,775,529 | |
| 397,529,082 | |
| 432,642,096 | |
| 414,076,080 | |
| 444,985,467 | |
| 534,007,691 | |
| 503,197,893 | |
| 483,973,050 | |
| 397,205,019 | |
| 381,471,060 | |
| 420,077,261 | |
| 466,452,180 | |
| 436,901,937 | |
| 457,370,183 | |
| 405,570,863 | |
| 397,514,153 | |
| 366,106,642 | |
| 446,138,038 | |
| 493,767,268 | |
| 440,085,743 | |
| 323,284,416 | |
| 295,673,640 | |
| 234,218,518 | |
| 216,344,529 | |
| 170,000,000 | |
| 212,700,000 | |
| 255,400,000 | |
| 255,650,000 | |
| 255,900,000 | |
| 266,900,000 | |
| 277,900,000 | |
| 293,350,000 | |
| 308,800,000 | |
| 289,100,000 | |
| 269,400,000 | |
| 248,550,000 | |
| 227,700,000 | |
| 209,750,000 | |
| 191,800,000 | |
| 191,750,000 | |
| 191,700,000 | |
| 174,250,000 | |
| 156,800,000 | |
| 185,400,000 | |
| 214,000,000 | |
| 101,300,000 | |
| 132,100,000 | |
| 127,800,000 | |
| 123,500,000 |